Elite Pharmaceuticals Inc insider trades: Elite Pharmaceuticals (ELTP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Elite Pharmaceuticals Inc reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | ELTP | ↓ Sell | 500,000 | $0.52 | $262K | Direct | Aug 26, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ELTP insiders
Open-market trades in the last 12 months
About Elite Pharmaceuticals Inc's insider trades
Elite Pharmaceuticals Inc is EVP Operations at Elite Pharmaceuticals (ELTP). Since Aug 22, 2025, it has reported no open-market purchases and 1 sale worth $262K on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELTP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.